New hope for young adults with hard-to-treat obesity: drug plus lifestyle beats lifestyle alone
NCT ID NCT05574439
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study tested whether adding the drug semaglutide to lifestyle counseling helps young adults (18-28) with early-onset obesity who previously did not lose enough weight through lifestyle changes alone. About 180-270 participants were split into groups based on their past response to lifestyle treatment. Those who had not lost enough weight were given either semaglutide or a placebo for 68 weeks. The main goal was to see how much their BMI changed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, ADOLESCENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Holbæk University Hospital
Holbæk, Region Zeeland, 4300, Denmark
-
University of Copenhagen, Department of Biomedical Sciences
Copenhagen, 2200, Denmark
Conditions
Explore the condition pages connected to this study.